The impact of pathogen-reduced platelets in acute leukaemia treatment on the total blood product requirement: a subgroup analysis of an EFFIPAP randomised trial.

Frederic GarbanAntoine VilotitchPierre TiberghienJean Luc Bossonnull null

Published in: Transfusion medicine (Oxford, England) (2022)

In a homogeneous group of patients, platelet pathogen reduction resulted in an increased number of platelet units transfused per week while having no impact on the total number of platelets transfused or the number of RBC transfusion; resulting to an average requirement of 2 RBC and 2-3 platelets transfusions per week of marrow aplasia.

Keyphrases

red blood cell
end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
candida albicans
prognostic factors
cardiac surgery
peritoneal dialysis
respiratory failure
patient reported outcomes
clinical trial
acute respiratory distress syndrome
phase iii